AlphAIAlphAI — Financial news for AI agents
grafa.comOCT 133 min read$UNH

UnitedHealth reports $112.7B Q3 revenue and raises outlook

UnitedHealth Group (NYSE:UNH) reported Q3 2026 revenue of $112.7B, earnings of $4.56 per share, and raised its full-year earnings outlook to at least $20.50 per share. The company's operating cash flow was $5.1B, with a net margin of 3.6%. UnitedHealthcare and Optum reported revenues of $86.3B and $66.9B, respectively.

Original reporting
grafa.com
Published Oct 13, 2026, 4:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 6:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
UnitedHealth reports $112.7B Q3 revenue and raises outlook — source image
Source · grafa.com
Decision brief

The 30-second read

$UNHBullishMed
01

Why it matters

For traders, the key decision input is the raised full-year adjusted net earnings target, supported by reported cash flow and cost ratio trends, which can drive estimate revisions and positioning in managed care.

02

Market read

A guidance raise with detailed cost metrics can move near-term expectations for UNH and influence sentiment across managed care.

03

What to watch

Optum and UnitedHealthcare segment earnings mix (and any assumptions behind medical cost ratio normalization) may be the real driver of whether the raised outlook is sustainable.

Relevance 9/10Novelty 8/10Timing: post-earnings, same-day guidance update

Background

The piece reports UnitedHealth’s Q3 2026 operating results and a raised full-year adjusted earnings outlook, including medical and operating cost ratios.

Company-level read

Ticker impact

$UNHBullishMedium confidence
Context

UnitedHealth reported Q3 2026 revenue of $112.7B and raised full-year adjusted net earnings outlook to at least $20.50 per share.

Expected impact

Likely upward bias as the market reprices full-year earnings expectations, tempered by attention to the 88.4% medical cost ratio.

Evidence & confidence

The article contains a fresh guidance raise ($20.50+ adjusted net earnings per share) plus multiple operating metrics (cash flow, cost ratios) that typically drive near-term estimate revisions.

Market effects

Sector

Reinforces managed-care earnings durability narrative, potentially supporting sentiment for health insurers and related healthcare services names.

Regional

Primarily US large-cap defensive sector sentiment; limited direct regional spillover beyond healthcare.

Global

Moderate, as US managed-care results can influence global healthcare risk appetite but are not a cross-border policy event.

Counterpoint

What could challenge this read

The medical cost ratio at 88.4% could signal underlying utilization pressure, meaning the guidance raise may rely on continued cost discipline that could reverse.

Key entities

  • company
    UnitedHealth Group

    Reports Q3 2026 revenue of $112.7B and raises full-year 2026 adjusted net earnings outlook to at least $20.50 per share.

Read at source← All news

StoryUnitedHealth posts $112.7 B Q3 revenue, $4.69 adjusted EPS and lifts FY‑2026 earnings outlook

Also covered by

5 outlets

Related articles

OCT 13
$UNHMedAI 9/10

UnitedHealth Group Inc (UNH) (Q3 2026) Earnings Call Highlights:

UnitedHealth Group (UNH) reported Q3 2026 revenue of $113 billion and adjusted EPS of $4.69, up from $2.92 a year ago. The company raised its full-year adjusted EPS guidance to at least $20.50. Key highlights include a 30% reduction in prior authorizations, AI-driven efficiencies, and Medicare Advantage margin expectations near the top of the 2% to 4% range. Challenges include elevated commercial medical trends and negative Medicaid margins.

gurufocus.com6 min
OCT 13
$UNHHighAI 9/10

UnitedHealth Group (UNH) Reports Strong Q3 2026 Results, Reinfor

UnitedHealth Group (UNH) reported Q3 2026 revenue of $113B and adjusted EPS of $4.69, reaffirming its full-year EPS guidance of at least $20.50. The company offers a 2.41% dividend yield with a 58% payout ratio and a 10.9% 3-year dividend growth rate. UNH's GF Score is 81/100, indicating strong fundamentals, particularly in profitability and momentum. Insider activity shows net selling, while 35 premium gurus hold the stock, with mixed sentiment among institutional investors.

gurufocus.com2 min
OCT 13
$UNHMedAI 8/10

UnitedHealth Raises Guidance: What It Means for Healthcare ETFs - UnitedHealth Group (NYSE:UNH)

UnitedHealth Group (NYSE:UNH) raised its full-year 2026 adjusted earnings guidance to at least $20.50 per share, up from $19.50-$20.00, exceeding analyst estimates. The company's medical care ratio improved, but included one-time benefits. Revenue from UnitedHealthcare and Optum Health declined, while Optum Insight and Optum Rx saw growth. The update may impact healthcare ETFs with UNH exposure, such as XLV, IHF, and VHT.

benzinga.com5 min
OCT 13
$UNHMedAI 8/10

UnitedHealth Group stock trims gains on profit outlook increase

UnitedHealth Group (UNH) raised its full-year profit forecast to at least $20.50 per share, up from $19.50-$20, after Q3 earnings beat estimates. The stock initially jumped 5% but trimmed gains. The company is executing a turnaround plan. Year-to-date, the stock is up 14%. Berkshire Hathaway previously sold its stake in UNH.

finance.yahoo.com4 min
OCT 13
$UNHHighAI 9/10

UnitedHealth Stock Wobbles Despite 61% Profit Jump, Boosted Outlook - UnitedHealth Group (NYSE:UNH)

UnitedHealth Group (NYSE:UNH) reported Q3 adjusted EPS of $4.69, up 61% YoY, and raised its 2026 adjusted EPS guidance to at least $20.50. Revenue was $112.69B, beating estimates. The company cited plan design and new pricing for improved medical care ratio. Management suggested 2027 consensus estimates may be too low. Shares initially rose 2% pre-market but reversed after the call.

benzinga.com6 min